Radbel et al. hypothesized that the development of viral myocarditis could be attributed to the decreased lymphocyte maturation due to the IL-6 antagonism [18], raising the concern of immunotherapy in COVID-19 cytokine storm syndrome (CSS). Here, IL6 is linked to viral myocarditis.